High mammographic breast density and its implications for the early detection of breast cancer

Journal of Medical Screening

Volumn 6, Issue 4, 1999, Pages 200-204

  Van Gils, Carla H ^a   Otten, Johannes D M ^a   Hendriks, Jan H C L ^b   Holland, Roland ^b   Straatman, Huub ^a   Verbeek, André L M ^a,b  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; Mammography

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER SCREENING; DIAGNOSTIC VALUE; DISEASE MODEL; EARLY DIAGNOSIS; IMAGE ANALYSIS; MAMMOGRAPHY; MATHEMATICAL MODEL; SIMULATION; VALIDATION PROCESS;

EID: 0033395248     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1136/jms.6.4.200     Document Type: Article

References (25)

1. Byrne C. Studying mammographic density: implications for understanding breast cancer. J Natl Cancer Inst 1997;89:531-3.
2. Bland KI. Risk factors as an indicator for breast cancer screening in asymptomatic patients. Maturitas 1987;9:135-61.
3. Ciatto S, Zappa M. A prospective study of the value of mammographic patterns as indicators of breast cancer risk in a screening experience. Eur J Radiol 1993;17:122-5.
4. Boyd NF, Byng JW, Jong RA, et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995;87:670-5.
5. Byrne C, Schairer C, Wolfe J, et al. Mammographic features and breast cancer risk: effects with time, age and menopause status. J Natl Cancer Inst 1995;87:1622-9.
6. Blanks RG, Moss SM, Wallis MG. Use of two view mammography compared with one view in the detection of small invasive cancers: further results from the National Health Service breast screening programme. J Med Screen 1997;4:98-101.
7. Jackson VP, Hendrick RE, Feig SA, et al. Imaging of the radiographically dense breast. Radiology 1993;188:297-301.
8. Weinreb JC, Newstead G. Controversies in breast MRI. Magn Reson Q 1994;10:67-83.
9. Van Gils CH, Otten JDM, Verbeek ALM, et al. Short communication: Breast parenchymal patterns and their changes with age. Br J Radiol 1995;68:1133-5.
10. Laya MB, Gallagher JC, Schreiman JS, et al. Effect of post-menopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology 1995;196:433-7.
11. Straatman H, Peer PGM, Verbeek ALM. Estimating lead time and sensitivity in a screening program without estimating the incidence in the screened group. Biometrics 1997;53:217-29.
12. Feig SA, Shaber GS, Patchefsky A, et al. Analysis of clinically occult and mammographically occult breast tumors. AJR Am J Roentgenol 1977;128:403-8.
13. Holland R, Hendriks JHCL, Mravunac M. Mammographically occult breast cancer. A pathologic and radiologic study. Cancer 1983;52:1810-19.
14. Bird RE, Wallace TW, Yankaskas BC. Analysis of cancers missed at screening mammography. Radiology 1992;184: 613-17.
15. National evaluation team of screening for breast cancer in the Netherlands. Landelijke evaluatie van bevolkingsonderzoek naar borstkanker in Nederland. Rotterdam: Institut Maatschappetyke Gezondheidszorg, Eur, 1996.
16. Visser O, Coebergh JWW, Schouten LJ. Incidence of cancer in the Netherlands 1993. Fifth report of the Netherlands Cancer Registry. Utrecht: Vereniging van Integrale Kankercentra, 1996.
17. Van Gils CH, Otten JDM, Verbeek ALM, et al. Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, the Netherlands. J Epidemiol Community Health 1998;52:267-71.
18. Mettler FA, Upton AC, Kelsey CA, et al. Benefits versus risks from mammography. A critical reassessment. Cancer 1996;77:903-9.
19. Heywang-Köbrunner SH, Viehweg P, Heinig A, et al. Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. European Radiology 1997;24:94-108.
20. Spicer DV, Ursin G, Parisky YR, et al. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst 1994;86:431-6.
21. Boyd NF, Greenberg C, Lockwood G, et al. Effects at two years of a low-fat high-carbohydrate diet on radiologic features of the breast: results from a randomized trial. J Natl Cancer Inst 1997;89:488-96.
22. Ursin G, Pike MC, Spicer DV, et al. Can mammographic densities predict effects of tamoxifen on the breast? J Natl Cancer Inst 1996;88:128-9.
23. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371-88.
24. Powles T, Eeles R, Ashley S, et al. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet 1998; 352:98-101.
25. Veronesi U, Maisonneuve P, Costa A, et al. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Lancet 1998;352:93-7.